JOINN Laboratories IPO: PHIP Points to Progress
JOINN is seeking to raise as much as $600 million through an HK IPO. The PHIP which disclose the 9M20 results reinforce our view that JOINN has...
324 Views
I-Mab Placement - Heading in the Right Direction
A group of shareholders plans to raise around US$200m via selling a 4.6% stake in I-Mab (IMAB US). We have previously covered the IPO as well.
226 Views
China Healthcare Weekly (Feb.5)
This article analyzed the results of the 4th volume-based purchase, the CTLA-4 antibody drug industry, the orthopedic implant device market, news...
203 Views
SK Bioscience IPO Preview - Biggest IPO in Korea in 1Q 2021
SK Bioscience is getting ready to complete its IPO in Korea in March. SK Bioscience will be the biggest IPO in Korea so far this year in 2021. The...
410 Views
Wuxi Biologics Placement - Laying the Groundwork for Future Growth
Wuxi Biologics (2269 HK) is looking to raise US$1.3bn in its primary placement to fund acquisitions and expand capacity. This is the company's...
375 Views